HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry

HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry

Abstract Background Human epidermal growth factor receptor 2 (HER2) positive breast carcinomas due to HER2 amplification are associated with aggressive behavior and a poor prognosis. Anti-HER2-targeted therapies are widely used to treat HER2-positive breast carcinomas with excellent outcomes. Accura...

Full description

Bibliographic Details
Main Authors: Laura Morsberger, Aparna Pallavajjala, Patty Long, Melanie Hardy, Rebecca Park, Rebecca Parish, Azin Nozari, Ying S. Zou
Format: Article
Language:English
Published: BMC 2022-11-01
Series:Cancer Cell International
Subjects:
Breast cancer
Fluorescence in situ hybridization
HER2 amplification
HER2 immunohistochemistry
HER2-positive breast carcinoma
Next-generation sequencing
Online Access:https://doi.org/10.1186/s12935-022-02761-1

Internet

https://doi.org/10.1186/s12935-022-02761-1

Similar Items